» Articles » PMID: 38496018

The Significance of Biomarkers of Inflammation in Predicting the Activity of Lupus Nephritis

Overview
Journal J Med Biochem
Specialty Biochemistry
Date 2024 Mar 18
PMID 38496018
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lupus nephritis (LN) is one of the most severe manifestations of systemic lupus erythematosus (SLE). There are increased studies examining the role of different markers that would facilitate diagnosis, LN activity monitoring, relapse occurrence, and the right time to introduce maintenance therapy. We aimed to examine the importance of determining the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), systemic immuneinflammatory index (SII) and systemic inflammatory response index (SIRI) in LN, comparing their significance with other standard parameters of active disease.

Methods: The clinical examination included 66 patients (34 with active and 32 with LN in remission) and 23 healthy controls. The investigated parameters were CRP, CBC, creatinine, albumin, GFR, C3, C4, ANA, anti-ds DNA Ab, in urine: sediment analysis, SLEDAI/r, proteinuria 24h and Up/cre. We determined the derived markers: NLR, PLR, SIRI, and SII and their correlation with other parameters of active disease.

Citing Articles

Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018.

Duan S, Tu Z, Duan L, Tu R BMC Gastroenterol. 2024; 24(1):463.

PMID: 39695411 PMC: 11658444. DOI: 10.1186/s12876-024-03557-5.


Biomarkers for systemic lupus erythematosus: A scoping review.

Zhang S, Xu R, Kang L Immun Inflamm Dis. 2024; 12(10):e70022.

PMID: 39364719 PMC: 11450456. DOI: 10.1002/iid3.70022.


The vascular endothelial growth factor as a candidate biomarker of systemic lupus erythematosus: a GRADE-assessed systematic review and meta-analysis.

Mangoni A, Zinellu A Clin Exp Med. 2024; 24(1):218.

PMID: 39259392 PMC: 11390800. DOI: 10.1007/s10238-024-01487-w.

References
1.
Fava A, Petri M . Systemic lupus erythematosus: Diagnosis and clinical management. J Autoimmun. 2018; 96:1-13. PMC: 6310637. DOI: 10.1016/j.jaut.2018.11.001. View

2.
Kim Y, Choi H, Jung S, Song J, Park Y, Lee S . Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology (Carlton). 2018; 24(7):711-717. DOI: 10.1111/nep.13491. View

3.
Suszek D, Gorak A, Majdan M . Differential approach to peripheral blood cell ratios in patients with systemic lupus erythematosus and various manifestations. Rheumatol Int. 2020; 40(10):1625-1629. PMC: 7452865. DOI: 10.1007/s00296-020-04669-3. View

4.
Ozdemir A, Baran E, Kutu M, Celik S, Yilmaz M . Could systemic immune inflammation index be a new parameter for diagnosis and disease activity assessment in systemic lupus erythematosus?. Int Urol Nephrol. 2022; 55(1):211-216. DOI: 10.1007/s11255-022-03320-3. View

5.
Kalkan M, Kalkan A, Gundes A, Yanartas M, Ozturk S, Gurbuz A . Neutrophil to lymphocyte ratio: a novel marker for predicting hospital mortality of patients with acute type A aortic dissection. Perfusion. 2015; 32(4):321-327. DOI: 10.1177/0267659115590625. View